Professor, Pathology, USC School of Medicine
Pathology
Dr. Andy E. Sherrod, MD
|
|
Give Review
Andy Sherrod practices Pathology. He studied medicine at Texas Tech University Health Sciences Center School of Medicine. He received 1 awards: "Super Doctor". Andy Sherrod has written publications. He has 14 publications published with PubMed. The lastest paper is: 'Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.' He accepts Medicare.
Publications
- Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
- Histological analysis of the kidney tumor-parenchyma interface.
- Significance of perivesical lymph nodes in radical cystectomy for bladder cancer.
- Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (...
- Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
- FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with sing...
- Molecular determinants of irinotecan efficacy.
- Primary solitary extragastrointestinal stromal tumor of the greater omentum coexisting with ulcerative colitis.
- Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
- Molecular determinants of cetuximab efficacy.
- Cytologic identification of reinke crystalloids in scrapings and imprints of fresh testicular tumors: a simple and rapid technique for intraoperative use.
- Pathologic quiz case: a 79-year-old woman with a black, ulcerated cecal tumor and 3 negative guaiac test results. Medullary adenocarcinoma of the colon, poorly differe...
- Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.
Schools
Texas Technical University
Scott White Meml Hospital
Los Angeles CoUsc
Doctors Specialties
- Cytopathology
- Pathology
Accepted Insurances
- Assurant Health
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
Texas A&M - Scott and White Memorial Hospital -
Texas Tech University Health Sciences Center School of Medicine
Hospital
-
Keck Hospital of USC
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104833581 |
| Last Name Of The Provider | SHERROD |
| First Name Of The Provider | ANDY |
| View All |
Similar Doctors
|
|
Dr. David S. Cassarino, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kingshuk Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith R. England, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wesley Y. Naritoku, MD |
|
|
Dr. Paul K. Pattengale, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Neda Moatamed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cassie M. Lee, MD |
|
|
Dr. Raul G. Simental-Pizarro, MD |
|
|
Dr. Honggang Shen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dolly Varshney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Schmidtknecht, MD
This Doctor is OpenDoctor Recommended.
|